• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy.rAd-p53 增强人胃癌细胞对化疗的敏感性。
World J Gastroenterol. 2011 Oct 14;17(38):4289-97. doi: 10.3748/wjg.v17.i38.4289.
2
Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells.氧化苦参碱与血管生成抑制剂NM-3对人胃癌细胞凋亡调控的协同作用。
World J Gastroenterol. 2007 Mar 28;13(12):1788-93. doi: 10.3748/wjg.v13.i12.1788.
3
Thermotherapy enhances oxaliplatin-induced cytotoxicity in human colon carcinoma cells.热疗增强奥沙利铂诱导的人结肠癌细胞毒性。
World J Gastroenterol. 2012 Feb 21;18(7):646-53. doi: 10.3748/wjg.v18.i7.646.
4
[Adenovirus mediated IL-24 gene expression suppresses gastric cancer cell growth in vitro].腺病毒介导的白细胞介素-24基因表达在体外抑制胃癌细胞生长
Sheng Wu Gong Cheng Xue Bao. 2009 Oct;25(10):1586-92.
5
Cellular and molecular mechanisms of the Ganoderma applanatum extracts induces apoptosis on SGC-7901 gastric cancer cells.灵芝提取物诱导 SGC-7901 胃癌细胞凋亡的细胞和分子机制。
Cell Biochem Funct. 2011 Apr;29(3):175-82. doi: 10.1002/cbf.1735. Epub 2011 Feb 24.
6
Synergistic gastric cancer inhibition by chemogenetherapy with recombinant human adenovirus p53 and epirubicin: an in vitro and in vivo study.重组人腺病毒 p53 与表柔比星联合化疗协同抑制胃癌:体外与体内研究。
Oncol Rep. 2010 Dec;24(6):1613-20.
7
Infection by Cx43 adenovirus increased chemotherapy sensitivity in human gastric cancer BGC-823 cells: not involving in induction of cell apoptosis.Cx43腺病毒感染增加人胃癌BGC-823细胞的化疗敏感性:不涉及诱导细胞凋亡。
Gene. 2015 Dec 15;574(2):217-24. doi: 10.1016/j.gene.2015.08.052. Epub 2015 Aug 28.
8
[Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].新型拓扑异构酶I抑制剂CPUY013对人胃腺癌BGC823细胞的体内外作用
Yao Xue Xue Bao. 2008 Aug;43(8):811-8.
9
Combination of metformin and oxaliplatin inhibits gastric cancer cell proliferation and induces apoptosis.二甲双胍联合奥沙利铂抑制胃癌细胞增殖并诱导其凋亡。
Acta Biochim Pol. 2022 Jun 15;69(2):321-326. doi: 10.18388/abp.2020_5750.
10
Effects of the ethylacetate extract of Orostachys japonicus on induction of apoptosis through the p53-mediated signaling pathway in human gastric cancer cells.朝鲜棘蝇乙酸乙酯提取物通过 p53 介导的信号通路诱导人胃癌细胞凋亡的作用。
Biol Pharm Bull. 2012;35(5):660-5. doi: 10.1248/bpb.35.660.

引用本文的文献

1
Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology.20年的健择®重组人5型腺病毒载体抑癌基因(rAd-p53)癌症基因治疗:个性化肿瘤学时代的首个同类人癌症基因治疗。
Genes Dis. 2023 Oct 31;11(4):101155. doi: 10.1016/j.gendis.2023.101155. eCollection 2024 Jul.
2
Tumor Tropism of DNA Viruses for Oncolytic Virotherapy.DNA 病毒的肿瘤趋向性用于溶瘤病毒治疗。
Viruses. 2023 Nov 16;15(11):2262. doi: 10.3390/v15112262.
3
Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair.p53家族异构体与胃癌:一段未竟之事的三角关系
Cancers (Basel). 2021 Feb 22;13(4):916. doi: 10.3390/cancers13040916.
4
Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer.重组人腺病毒 p53 与姜黄素联合治疗肝癌的效果
Exp Ther Med. 2020 Nov;20(5):18. doi: 10.3892/etm.2020.9145. Epub 2020 Aug 26.
5
A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer.胃癌多药耐药机制的研究进展综述
Onco Targets Ther. 2020 Feb 28;13:1797-1807. doi: 10.2147/OTT.S239336. eCollection 2020.
6
Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells.适应与存活:耐药性胃癌细胞的细胞内外重塑。
Int J Mol Sci. 2019 Jul 31;20(15):3736. doi: 10.3390/ijms20153736.
7
Therapeutic effects of lenvatinib in combination with rAd-p53 for the treatment of non-small cell lung cancer.乐伐替尼联合重组腺病毒-p53治疗非小细胞肺癌的疗效
Oncol Lett. 2018 Nov;16(5):6573-6581. doi: 10.3892/ol.2018.9428. Epub 2018 Sep 11.
8
Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway.使用重组新城疫病毒递送的p53过表达通过调节凋亡信号通路诱导胶质瘤细胞凋亡。
Exp Ther Med. 2018 May;15(5):4522-4530. doi: 10.3892/etm.2018.5935. Epub 2018 Mar 8.
9
Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial.重组人腺病毒-p53联合化疗治疗局部晚期宫颈癌的疗效:一项临床试验。
Oncol Lett. 2017 May;13(5):3676-3680. doi: 10.3892/ol.2017.5901. Epub 2017 Mar 24.
10
Molecular mechanisms of chemoresistance in gastric cancer.胃癌化疗耐药的分子机制
World J Gastrointest Oncol. 2016 Sep 15;8(9):673-81. doi: 10.4251/wjgo.v8.i9.673.

本文引用的文献

1
Advances in the pharmacological treatment of gastro-oesophageal cancer.胃食管交界癌的药理学治疗进展。
Drugs Aging. 2009;26(8):627-46. doi: 10.2165/11315740-000000000-00000.
2
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.超越李-佛美尼综合征:携带p53种系突变家族的临床特征
J Clin Oncol. 2009 Mar 10;27(8):1250-6. doi: 10.1200/JCO.2008.16.6959. Epub 2009 Feb 9.
3
TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.TP53突变与肝细胞癌:对肝癌病因及发病机制的见解
Oncogene. 2007 Apr 2;26(15):2166-76. doi: 10.1038/sj.onc.1210279.
4
Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.生殖细胞肿瘤在体外的细胞周期进程及对顺铂的反应
Int J Oncol. 2006 Aug;29(2):471-9.
5
Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.血小板活化因子通过激活核因子-κB诱导黑色素瘤细胞系中抗凋亡因子的上调。
Cancer Res. 2006 May 1;66(9):4681-6. doi: 10.1158/0008-5472.CAN-05-3186.
6
Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers.中国基因治疗药物现状:重组人Ad-p53制剂用于癌症治疗。
Hum Gene Ther. 2005 Sep;16(9):1016-27. doi: 10.1089/hum.2005.16.1016.
7
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation.与种系TP53 R337H突变相关的肾上腺皮质肿瘤的外显率。
J Med Genet. 2006 Jan;43(1):91-6. doi: 10.1136/jmg.2004.030551. Epub 2005 Jul 20.
8
Successful management of postoperative recurrence of hepatocellular carcinoma with p53 gene therapy combining transcatheter arterial chemoembolization.经导管动脉化疗栓塞联合p53基因治疗成功管理肝细胞癌术后复发
World J Gastroenterol. 2005 Jun 28;11(24):3803-5. doi: 10.3748/wjg.v11.i24.3803.
9
Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease.癌症易感性慢性炎症和氧自由基过载疾病中的一氧化氮与p53
Environ Mol Mutagen. 2004;44(1):3-9. doi: 10.1002/em.20024.
10
Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study.使用功能检测和通用寡核苷酸阵列对肺癌患者活检样本进行快速灵敏的p53改变分析:一项前瞻性研究。
Clin Cancer Res. 2004 May 15;10(10):3479-89. doi: 10.1158/1078-0432.CCR-0994-03.

rAd-p53 增强人胃癌细胞对化疗的敏感性。

rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy.

机构信息

Department of Gastroenterology, First People's Hospital of Xuzhou, Xuzhou 221002, Jiangsu Province, China.

出版信息

World J Gastroenterol. 2011 Oct 14;17(38):4289-97. doi: 10.3748/wjg.v17.i38.4289.

DOI:10.3748/wjg.v17.i38.4289
PMID:22090785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3214704/
Abstract

AIM

To investigate potential antitumor effects of rAd-p53 by determining if it enhanced sensitivity of gastric cancer cells to chemotherapy.

METHODS

Three gastric cancer cell lines with distinct levels of differentiation were treated with various doses of rAd-p53 alone, oxaliplatin (OXA) alone, or a combination of both. Cell growth was assessed with an 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-diphenytetrazoliumromide assay and the expression levels of p53, Bax and Bcl-2 were determined by immunohistochemistry. The presence of apoptosis and the expression of caspase-3 were determined using flow cytometry.

RESULTS

Treatment with rAd-p53 or OXA alone inhibited gastric cancer cell growth in a time- and dose-dependent manner; moreover, significant synergistic effects were observed when these treatments were combined. Immunohistochemical analysis demonstrated that treatment with rAd-p53 alone, OXA alone or combined treatment led to decreased Bcl-2 expression and increased Bax expression in gastric cancer cells. Furthermore, flow cytometry showed that rAd-p53 alone, OXA alone or combination treatment induced apoptosis of gastric cancer cells, which was accompanied by increased expression of caspase-3.

CONCLUSION

rAd-p53 enhances the sensitivity of gastric cancer cells to chemotherapy by promoting apoptosis. Thus, our results suggest that p53 gene therapy combined with chemotherapy represents a novel avenue for gastric cancer treatment.

摘要

目的

通过确定重组人腺病毒-53(rAd-p53)是否增强胃癌细胞对化疗的敏感性来研究其潜在的抗肿瘤作用。

方法

用不同剂量的 rAd-p53、奥沙利铂(OXA)或两者联合处理三种分化程度不同的胃癌细胞系。用 3-(4,5)-二甲基噻唑(-z-y1)-3,5-二苯基四氮唑溴盐比色法评估细胞生长情况,并用免疫组织化学法测定 p53、Bax 和 Bcl-2 的表达水平。用流式细胞术检测凋亡的存在和 caspase-3 的表达。

结果

rAd-p53 或 OXA 单独处理可呈时间和剂量依赖性抑制胃癌细胞生长;此外,这些处理联合时观察到显著的协同作用。免疫组织化学分析表明,rAd-p53 单独、OXA 单独或联合处理可降低胃癌细胞中 Bcl-2 的表达并增加 Bax 的表达。此外,流式细胞术显示 rAd-p53 单独、OXA 单独或联合处理可诱导胃癌细胞凋亡,并伴有 caspase-3 的表达增加。

结论

rAd-p53 通过促进细胞凋亡增强胃癌细胞对化疗的敏感性。因此,我们的结果表明 p53 基因治疗联合化疗为胃癌治疗提供了新途径。